Reiss’ Finance Bro Flash Mob Goes Viral on TikTokby Mark Eisenberg 20.06.2024Reiss's viral TikTok flash mob in London's financial district taps into a popular "finance bro" trend, boosting engagement with 661,500 ...
ASE Technology Hits 12-Month High at $11.78 Amid Major Investmentsby Lilu Anderson 20.06.2024ASE Technology (NYSE:ASX) hits a 12-month high at $11.78, earning a "buy" rating from StockNews.com; strong performance and investor interest ...
VanEck Introduces Bitcoin ETF on Australia’s Main Exchangeby John Darbie 20.06.2024VanEck launches a Bitcoin ETF on Australia’s stock exchange; insights on AI in trading, African market trends, and asset allocation ...
SEC Ends Ethereum 2.0 Inquiry Following ConsenSys Lawsuitby John Darbie 20.06.2024SEC halts Ethereum 2.0 probe post ConsenSys lawsuit win; legal clarity sought for crypto growth. Ethereum spikes 5%, signaling market ...
Ripple’s Top Lawyer Questions SEC’s Ethereum Stanceby John Darbie 20.06.2024Ripple's top lawyer questions SEC's sudden drop of Ethereum probe, raising concerns over Ether's legal status and ongoing regulatory uncertainty.
AI Investments: Hype vs. Reality in 2024by Lilu Anderson 20.06.2024Are investors starting to see through AI hype? Some tech firms thrive, but many falter as market demands real results ...
Bernstein Initiates Coverage on Three Key Financial Firmsby Mark Eisenberg 20.06.2024Discover Bernstein's insights on Bajaj Finance, IndusInd Bank, & Muthoot Finance, highlighting growth in India's robust banking and niche lending ...
India’s FIU Fines Binance $2.2M for AML Violationsby Mark Eisenberg 20.06.2024"India fines Binance $2.2M for AML violations. A reminder of stringent compliance for crypto exchanges. Stay updated on crypto regulations."
Fortress Biotech Sees Upgrades Amid Investor Shiftsby Lilu Anderson 20.06.2024"Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."
ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cutby Mark Eisenberg 20.06.2024Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...